Chi-Ting Huang

Chi-Ting Huang is the Senior Director, CMC at Invetx. Her role is implementing state-of-the-art manufacturing and development technologies to bring pioneering biotherapeutics to animal health. Chi-Ting has 20 years of experience developing biotherapeutics. Lead development teams for the production of several novel biotherapeutics (e.g. biosimilars, antibody-drug conjugates, highly glycosylated fusion proteins, TGF-beta proteins). Experience spans the initial IND for luspatercept as well as characterization for the commercialization of the Infuse(TM) Bone Graft.

Chi-Ting holds a BS from the University of Illinois – Urbana.